Summer Road LLC's Form 4 filing
Ocular Therapeutix, Inc (OCUL) · filed Jan 24, 2022
- Accession no.
- 0001567619-22-001593
- Filed
- Jan 24, 2022
- Trade date
- Jan 20-24, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $405.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Summer Road LLCCIK 0001604873 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock, $0.0001 par value per share | PPurchaseAcquired | +17,948 | $5.70F4 | +$102,303.6 | 5,832,709 | Indirect | |
| Jan 21, 2022 | Common Stock, $0.0001 par value per share | PPurchaseAcquired | +12,152 | $5.56F5 | +$67,565.12 | 5,844,861 | Indirect | |
| Jan 24, 2022 | Common Stock, $0.0001 par value per share | PPurchaseAcquired | +44,400 | $5.31F6 | +$235,764 | 5,889,261 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average set forth in this line item. On January 20, 2022, the Reporting Person acquired 17,948 shares of Common Stock at a weighted average price of $5.7045 (ranging from a low of $5.64 and a high of $6.06). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average set forth in this line item. On January 21, 2022, the Reporting Person acquired 12,152 shares of Common Stock at a weighted average price of $5.5572 (ranging from a low of $5.45 and a high of $5.68). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average set forth in this line item. On January 24, 2022, the Reporting Person acquired 44,400 shares of Common Stock at a weighted average price of $5.3129 (ranging from a low of $5.18 and a high of $5.68). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.